exteRNA
Business Services · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Melbourne, Victoria, AustraliaWebsite
www.externabio.comRevenue
$6 MillionIndustry
About exteRNA
exteRNA Org Chart
Is exteRNA your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once exteRNA has new funding data
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when exteRNA launches new products
Earning: See what the market has to say on exteRNA recently announced quarterly report
exteRNA, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at exteRNA
Check if exteRNA has recently received funding, and reach out quickly before it becomes old news!
Click to see if exteRNA had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if exteRNA is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined exteRNA as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
exteRNA is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
exteRNA is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about exteRNA.
exteRNA financials insights
Gather financial insights about exteRNA, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Angel/Seed
$11M
Angel/Seed
$11M
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding exteRNA
Founded in 2024, exteRNA is dedicated to developing novel small molecule therapeutics that target RNA processing pathways. With a team of experienced scientists and industry experts, the company is committed to advancing the next generation of small molecule therapies for unmet medical needs.... Read More